Identification of PML/RARα rearrangements in suspected acute promyelocytic leukemia using fluorescence in situ hybridization of bone marrow smears:: a comparison with cytogenetics and RT-PCR in MRC ATRA trial patients

被引:8
|
作者
Iqbal, S
Grimwade, D
Chase, A
Goldstone, A
Burnett, A
Goldman, JM
Swirsky, D
机构
[1] Imperial Coll Sch Med, Dept Haematol, London, England
[2] UCL Hosp, Dept Haematol, London, England
[3] Guys Kings & St Thomas Sch Med, Div Med & Mol Genet, London, England
[4] Univ Wales Coll Cardiff, Cardiff CF1 3NS, S Glam, Wales
关键词
D O I
10.1038/sj.leu.2401688
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:950 / 953
页数:4
相关论文
共 12 条
  • [1] Identification of PML/RARα rearrangements in suspected acute promyelocytic leukemia using fluorescence in situ hybridization of bone marrow smears: a comparison with cytogenetics and RT-PCR in MRC ATRA trial patients
    S Iqbal
    D Grimwade
    A Chase
    A Goldstone
    A Burnett
    JM Goldman
    D Swirsky
    Leukemia, 2000, 14 : 950 - 953
  • [2] Identification of PML/RARα rearrangements in suspected acute promyelocytic leukaemia (APL) using in situ hybridisation on bone marrow (BM) smears:: A comparison of cytogenetics with RT-PCR in MRC ATRA trial patients.
    Iqbal, S
    Grimwade, D
    Chase, A
    Goldstone, AH
    Burnett, AK
    Goldman, JM
    Swirsky, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 : 35 - 35
  • [3] Detecting PML-RARα transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR
    Zhu Hong-Hu
    Liu Yan-Rong
    Qin Ya-Zhen
    Bin, Jiang
    Shan Fu-Xiang
    Wu Shu-Lan
    Yang Ping-Di
    Re, Zhao
    Lu Dao-Pei
    CHINESE MEDICAL JOURNAL, 2007, 120 (20) : 1803 - 1808
  • [4] Detecting PML-RARα transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR
    ZHU Honghu LIU Yanrong QIN Yazhen JIANG Bin SHAN Fuxiang WU Shulan YANG Pingdi ZHAO Jie LU Daopei Institute of HematologyPeking University Peoples HospitalBeijing China Zhu HHLiu YRQin YZJiang B and Lu DPBeijing Daopei HospitalBeijing China Jiang BShan FXWu SLYang PDZhao J and Lu DP
    ChineseMedicalJournal, 2007, 120 (20) : 1803 - 1808
  • [5] Detecting PML-RARα transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR
    ZHU Hong-hu LIU Yan-rong QIN Ya-zhen JIANG Bin SHAN Fu-xiang WU Shu-lan YANG Ping-di ZHAO Jie LU Dao-pei Institute of Hematology
    中华医学杂志(英文版), 2007, (20) : 1803 - 1808
  • [6] Identification of a new cryptic PML-RARα fusion gene without t(15;17) and biallelic CEBPA mutation in a case of acute promyelocytic leukemia: a case detected only by RT-PCR but not cytogenetics and FISH
    Zhang, Zhanglin
    Xu, Yawen
    Jiang, Mei
    Kong, Fancong
    Chen, Zhiwei
    Liu, Shuyuan
    Li, Fei
    CANCER BIOLOGY & THERAPY, 2020, 21 (04) : 309 - 314
  • [7] Quantitative real-time RT-PCR analysis of PML-RARα-mRNA in acute promyelocytic leukemia:: assessment of prognostic significance in adult patients from intergroup protocol 0129
    Gallagher, RE
    Yeap, BY
    Bi, WL
    Livak, KJ
    Beaubier, N
    Rao, S
    Bloomfield, CD
    Appelbaum, FR
    Tallman, MS
    Slack, JL
    Willman, CL
    BLOOD, 2003, 101 (07) : 2521 - 2528
  • [8] Feasibility and clinical significance of real time quantitative reverse transcription polymerase chain reaction (RT-PCR) assay in the study of PML-RARα fusion transcript in patients with acute promyelocytic leukemia.
    Gu, BW
    Hu, J
    Xu, L
    Yan, H
    Jin, WR
    Zhu, YM
    Zhao, WL
    Niu, C
    Cao, Q
    Su, XY
    Ying, HY
    Chen, Y
    Xiong, SM
    Shen, ZX
    Chen, Z
    Chen, SJ
    BLOOD, 2000, 96 (11) : 313A - 313A
  • [9] Quantitative kinetics of PML/RARa transcripts using real-time RT-PCR according to the use of cytarabine for consolidation in patients with newly diagnosed acute promyelocytic leukemia: A prospective randomized trial.
    Seok, L
    Kim, YL
    Hwang, JY
    Kim, YJ
    Park, YH
    Shin, HJ
    Park, CY
    Min, CK
    Kim, DW
    Lee, JW
    Min, WS
    Kim, CC
    BLOOD, 2001, 98 (11) : 194B - 194B
  • [10] Monitoring chronic myeloid leukemia (CML) response to tyrosine kinase inhibitors (TKI) and homoharringtonine (HHT) using peripheral blood (PB) fluorescence in situ hybridization (FISH) and quantitative RT-PCR (Q-PCR): Are bone marrow biopsies still needed?
    Khoury, H. J.
    Lima, L.
    Saxe, D.
    Mann, K. P.
    Arellano, M.
    Heffner, L.
    Bernal-Mizrachi, L.
    McLemore, M.
    Langston, A.
    Winton, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)